Inhibin B and anti-Müllerian hormone/Müllerian-inhibiting substance may contribute to the male bias in autism

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Pankhurst, M W ^a   McLennan, I S ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Boys; congential disorders; Sertoli cell hormones; sex bias; superfamily; testes; TGF

Indexed keywords

INHIBIN B; MUELLERIAN INHIBITING FACTOR; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; INHIBIN;

ARTICLE; AUTISM; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; GENETIC TRAIT; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SOCIAL INTERACTION; STEREOTYPY; BLOOD; CASE CONTROL STUDY; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; METABOLISM; SERTOLI CELL; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STATISTICAL MODEL;

ANTI-MULLERIAN HORMONE; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INHIBINS; LINEAR MODELS; MALE; SERTOLI CELLS; SEX FACTORS; SIGNAL TRANSDUCTION;

EID: 84874289247     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.72     Document Type: Article

References (41)

1. Levy SE, Mandell DS, Schultz RT. Autism. Lancet 2009; 374: 1627-1638.
2. Courchesne E, Campbell K, Solso S. Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 2010; 1380: 138-145.
3. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007; 28: 235-258.
4. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T et al. Strong association of de novo copy number mutations with autism. Science 2007; 316: 445-449.
5. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372.
6. Geschwind DH. Genetics of autism spectrum disorders. Trends Cogn Sci 2011; 15: 409-416.
7. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Dis 2003; 33: 365-382.
8. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008; 9: 341-355.
9. MacLaughlin DT, Donahoe PK. Sex determination and differentiation. New Eng J Med 2004; 350: 367-378.
10. de Kretser DM, Buzzard JJ, Okuma Y, O'Connor AE, Hayashi T, Lin SY et al. The role of activin, follistatin and inhibin in testicular physiology. Mol Cell Endocrinol 2004; 225: 57-64.
11. Morgan K, Meredith J, Kuo J-YA, Bilkey DK, McLennan IS. The sex bias in novelty preference of preadolescent mouse pups may require testicular Müllerian inhibiting substance. Behav Brain Res 2011; 221: 304-306.
12. Wang PY, Koishi K, McGeachie AB, Kimber M, Maclaughlin DT, Donahoe PK et al. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc Natl Acad Sci USA 2005; 102: 16421-16425.
13. Wang PY, Protheroe A, Clarkson AN, Imhoff F, Koishi K, McLennan IS. Müllerian Inhibiting Substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci USA 2009; 106: 7203-7208.
14. Giedd JN, Rapoport JL. Structural MRI of pediatric brain development: what have we learned and where are we going? Neuron 2010; 67: 728-734.
15. Morgan K, Dennis NA, Ruffman T, Bilkey DK, McLennan IS. The stature of boys is inversely correlated to the levels of their Sertoli cell hormones: do the testes restrain the maturation of boys? PLoS One 2011; 6: e20533.
16. Lord C, Rutter M, Le Couteur A. Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Dis 1994; 24: 659-685.
17. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002; 6: 248-254.
18. Arnold A. Sex chromosomes and brain gender. Nat Rev Neurosci 2004; 5: 701-708.
19. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S et al. Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 1996; 81: 571-576.
20. Andersson AM, Juul A, Petersen JH, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 1997; 82: 3976-3981.
21. Aksglaede L, Sorensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB et al. Changes in anti-Mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 2010; 95: 5357-5364.
22. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010; 467: 832-838.
23. David L, Feige JJ, Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 2009; 20: 203-212.
24. Lowery JW, de Caestecker MP. BMP signaling in vascular development and disease. Cytokine Growth Factor Rev 2010; 21: 287-298.
25. Santibanez JF, Quintanilla M, Bernabeu C. TGF-beta/TGF-beta receptor system and its role in physiological and pathological conditions. Clin Sci 2011; 121: 233-251.
26. Cameron VA, Nishimura E, Mathews LS, Lewis KA, Sawchenko PE, Vale WW. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology 1994; 134: 799-808.
27. Soderstrom S, Bengtsson H, Ebendal T. Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell Tissue Res 1996; 286: 269-279.
28. Shoji-Kasai Y, Ageta H, Hasegawa Y, Tsuchida K, Sugino H, Inokuchi K. Activin increases the number of synaptic contacts and the length of dendritic spine necks by modulating spinal actin dynamics. J Cell Sci 2007; 120: 3830-3837.
29. Ebendal T, Bengtsson H, Soderstrom S. Bone morphogenetic proteins and their receptors-potential functions in the brain. J Neurosci Res 1998; 51: 139-146.
30. Sanchez-Camacho C, Bovolenta P. Emerging mechanisms in morphogen-mediated axon guidance. Bioessays 2009; 31: 1013-1025.
31. Liu A, Niswander LA. Bone morphogenetic protein signalling and vertebrate nervous system development. Nat Rev Neurosci 2005; 6: 945-954.
32. Stipursky J, Gomes FC. TGF-beta1/SMAD signaling induces astrocyte fate commitment in vitro: implications for radial glia development. Glia 2007; 55: 1023-1033.
33. Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS One 2008; 3: e2863.
34. Crofton PM, Evans AE, Wallace AM, Groome NP, Kelnar CJ. Nocturnal secretory dynamics of inhibin B and testosterone in pre-and peripubertal boys. J Clin Endocrinol Metab 2004; 89: 867-874.
35. Dennis NA, Houghton LA, Jones GT, van Rij AM, Morgan K, McLennan IS. The level of serum anti-mullerian hormone correlates with vitamin D status in men and women but not in boys. J Clin Endocrinol Metab 2012; 97: 2450-2455.
36. Guibourdenche J, Lucidarme N, Chevenne D, Rigal O, Nicolas M, Luton D et al. Anti-Mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol 2003; 211: 55-63.
37. Morpurgoa PS, Cetinb I, Borgatoa S, Cortelazzia D, Nobile-DeSantisb MS, Vaghia I et al. Circulating levels of inhibin A, inhibin B and activin A in normal and intrauterine growth restricted (IUGR) fetuses. Eur J Obst Gyn Reprod Biol 2004; 117: 38-44.
38. Bergada I, Milani C, Bedecarras P, Andreone L, Ropelato MG, Gottlieb S et al. Time course of the serum gonadotropin surge, inhibins, and anti-Mullerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab 2006; 91: 4092-4098.
39. Wudy SA, Dorr HG, Solleder C, Djalali M, Homoki J. Profiling steroid hormones in amniotic fluid of midpregnancy by routine stable isotope dilution/gas chromatography-mass spectrometry: reference values and concentraions in fetuses at risk for 21-hydroxylase deficiency. J Clin Endo Metab 1999; 84: 2724-2728.
40. Wudy SA, Wachter UA, Homoki J, Teller WM. 17alpha-hydroxyprogesterone, 4-androstenedione and testosterone profiled by routine stable isotope dlution/gas chromatography-mass spectrometry of children. Ped Res 1995; 38: 76-80.
41. Takagi S, Yoshida T, Tsubata K, Ozaki H, Fujii TK, Nomura Y et al. Sex differences in fetal gonadotropins and androgens. J Steroid Biochem 1977; 8: 609-620.